Preparation of antibodies against TXR1 and construction of a new DNA tumor vaccine-Reference-Cited by-同舟云学术

Preparation of antibodies against TXR1 and construction of a new DNA tumor vaccine

Published:2022-02 Issue: Volume:103 Page:108505
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Sun Yuanjie,Zhang Xiyang,Yang Shuya,Hu Chenchen,Pan Jingyu,Liu Tianyue,Ding Jiaqi,Han Chenying,Huang Yinan,Yang Kun

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shaanxi Province

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference34 articles.

1. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis;de Martel;Lancet Global Health,2020

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: Cancer J. Clin.,2018

3. Tumour-associated antigens and their anti-cancer applications;Liu;Eur. J. Cancer Care,2017

4. Expression in algae of a chimeric protein carrying several epitopes from tumor associated antigens;Hernández-Ramírez;Int. J. Biol. Macromol.,2020

5. AI Myhr, DNA vaccines: regulatory considerations and safety aspects, Curr. Issues Mol. Biol. 22 (2017) 79–88. Epub 2016/10/06. doi: 10.21775/cimb.022.079. PubMed PMID: 27705898.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative polyadenylation-related genetic variants contribute to bladder cancer risk;The Journal of Biomedical Research;2023

2. COVID-19 mRNA vaccines: Platforms and current developments;Molecular Therapy;2022-05